The Problem

Most Vision Loss is Preventable

Picture of many people

An estimated 80 million people in the US general population have vision loss due to disease (diabetes, macular degeneration, etc.).

Infographic of 1 icon of a eye specialist contrasted with many people

There is only 1 Eye Specialist for every 17,000 Americans.

Illustration of 40 people shaded in white, and the other 60 shaded in grey.

It’s estimated that, only 40% of patients had their annual eye exam.

Our Strategy

3 Tiered Approach

Tier 1
Diabetic Patients

Enables the screening of Diabetic Retinopathy for patients with Type 1 and Type 2 diabetes.

Icon of blood
30M diabetics in the US
Tier 2
Expand to Eyecare Diagnostics

Enables the screening of Age-Related Macular Degeneration, Optic Nerve suspicious for Glaucoma, etc.

Icon of an eye
80M suffer from vision-threatening diseases.
Tier 3
Global Analytics

Enables the screening of Parkinson’s, Stroke, Heart Disease, and Kidney Disease, etc.

Icon of a brain, heart, and kidneys
200M have the aforementioned diseases
Our Solution

The Spect Platform

Today, we invented a vertically integrated platform from the ground up that solves all the pain-points that are routine with conventional retinal exams.

This exam is reimbursable through CPT billing, satisfies quality metrics (HEDIS/MIPs), and can be used for value based care.

Diagram of Spect's Platform. 
1. Spect's Imaging Device
2. Spect's Telemedicine Platform
3. Spect's Retinal Image Grader

The Imaging Device (1) sends a human in the loop/AI assisted retinal image to the telemedicine platform, which is then graded by Spect's retinal image grader, sending a graded report back to the patient and operator.

Current Solutions:
Built for Specialists

Current solutions are inflexible, costly, and difficult to use.

Icon of money

Quality Results

Image gradability around 50-60%

Icon of an hour glass

Intensive Setup Costs

Hours of training, difficult to integrate in clinical workflow, immobile

Icon of money

Large Upfront Capital Expense

Starting price from $5,000+

Our Solution:
Built for all Healthcare Staff

Our solution is a frictionless workflow and enables all healthcare staff to obtain quick results.

Icon of blue camera

Quick Quality Results

Exams in 3 minutes or less and Image gradability above 95%

Icon of a laptop and stricken out clock/timer

No Initial Setup Costs

Hours of training, difficult to integrate in clinical workflow, immobile

Icon of a crossed-out dollar sign

No Capital Expense

Cost financed through a low monthly fee or other payment structure that meets your needs

Screenable Diseases with our Platform

We’re always looking to expand the diseases our platform tracks.

Common Eye Diseases

  • Stages of Diabetic Retinopathy with and without macular edema
  • Stages of Dry Macular Degeneration
  • End Stage Wet Macular Degeneration
  • Myopic Degeneration
  • Epiretinal Membrane
  • Retinal View Occlusion

Rarer Eye Diseases

  • Choroidal Nevus
  • Macular Hole
  • Optic Nerve suspicious for of Glaucoma
  • Optic Disc Edema
  • And Many More

Markets We Serve

The Spect solution is proudly deployed in over 8 states and 10 cities in the United States. We are heavily focused on screening the Senior Population.

Icon of home
At-Home Health
Icon of hospital
FQHC
Icon of medical briefcase
In-Clinic Offices
Icon of dollar sign
Medicare/ Medicaid

Interested in Learning More?

Request A Demo

Want to learn more?

Contact UsVertical Spect Logo